Financial Overview - The company raised total gross proceeds of $230 million from the Initial Public Offering of 23,000,000 Units at $10.00 per Unit [108]. - As of March 31, 2023, the company had approximately $236.5 million in cash held in the Trust Account, intended for the initial Business Combination [114]. - For the three months ended March 31, 2023, the company reported a net income of approximately $1.5 million, driven by $2.1 million in income from investments held in the Trust Account [120]. - The company incurred a working capital deficit of approximately $996,000 as of March 31, 2023 [112]. - The underwriters fully exercised their over-allotment option, generating an additional $30 million in gross proceeds [124]. - The company has incurred operating and formation expenses of approximately $278,000 for the three months ended March 31, 2023 [120]. - The company has no off-balance sheet arrangements as of March 31, 2023 [122]. - The company has entered into a Fee Reduction Agreement, reducing deferred underwriting commissions by approximately $8.1 million [126]. Business Combination and Redemption - The company has until April 12, 2024, to consummate a Business Combination, or it will face mandatory liquidation [115]. - The company plans to use substantially all funds in the Trust Account for the initial Business Combination and subsequent operations [114]. - Holders of 18,336,279 Class A ordinary shares redeemed their shares for cash at approximately $10.30 per share, totaling an aggregate redemption amount of approximately $189 million [138]. - After redemptions, the balance in the Trust Account was approximately $48 million [138]. - The Sponsor advanced $160,000 for the first Contribution on April 13, 2023, and subsequently deposited another $160,000 into the Trust Account on May 12, 2023 [141]. - On April 10, 2023, shareholders approved the Extension Proposal, Redemption Limitation Amendment Proposal, and Founder Share Amendment Proposal [136]. - Following the Founder Conversion on May 9, 2023, there were 8,665,842 Class A ordinary shares and 1,747,879 Class B ordinary shares issued and outstanding [142].

Financial Performance - For the year ended December 31, 2022, the company reported a net income of approximately $9.3 million, which included a gain of approximately $7.5 million from the change in fair value of derivative warrant liabilities[340][349]. - The Company reported an accumulated deficit of $(13,192,169) as of December 31, 2022, compared to $(19,266,026) as of December 31, 2021[378]. - For the year ended December 31, 2022, the net income was $9,286,803, compared to $9,337,120 for the previous year[379]. - The total other income for the year ended December 31, 2022, was $10,729,865, an increase from $9,952,967 in the prior year[379]. - The basic net income per share for Class A ordinary shares was $0.32 for the year ended December 31, 2022, down from $0.84 in 2021[379]. Cash and Assets - As of December 31, 2022, the company had approximately $234.4 million in cash held in the Trust Account, intended for the initial business combination[342]. - The company had cash of $70,236 at the end of the period, a decrease from $611,620 at the beginning of the period[383]. - The balance in the Company's Trust Account after redemptions is approximately $48 million[364]. - The total number of Class B ordinary shares issued to the Sponsor was 5,750,000, with an aggregate payment of $25,000[431]. - The Company held investments in the Trust Account amounting to $234,364,451, an increase from $231,151,505 as of December 31, 2021, representing a growth of approximately 1.0%[458][459]. Business Combination and Operations - The company has until May 12, 2023, or April 12, 2024, if extensions are exercised, to consummate a business combination, or it will face mandatory liquidation[343][345]. - The company has not yet selected a business combination target and has not initiated substantive discussions with any potential targets[332]. - The Company received shareholder approval to extend the deadline for completing an initial business combination from April 12, 2023, to May 12, 2023[364]. - The Company has the option to extend the deadline for completing a Business Combination to April 12, 2024, if all extensions are exercised[389]. - The Company will redeem Public Shares at a per-share price equal to the aggregate amount in the Trust Account if a Business Combination is not completed, which may be less than the Initial Public Offering price of $10.05[397]. Shareholder Actions and Redemptions - Approximately 18,336,279 Class A ordinary shares were redeemed for cash at a price of approximately $10.30 per share, totaling an aggregate redemption amount of approximately $189 million[364]. - The Company received shareholder approval for a redemption of 18,336,279 Class A ordinary shares at approximately $10.30 per share, totaling an aggregate redemption amount of approximately $189 million[469]. - Following the redemptions, the balance in the Company's Trust Account is approximately $48 million[469]. Liabilities and Financial Health - The company had a working capital deficit of approximately $719,000 as of December 31, 2022[339]. - The Company’s financial statements indicate substantial doubt about its ability to continue as a going concern due to insufficient cash and working capital[370]. - Total liabilities decreased from $20,385,793 in December 31, 2021, to $13,495,731 in December 31, 2022[377]. - The total liabilities as of December 31, 2022, were $373,000, which included public warrants liability of $230,000 and private placement warrants liability of $143,000[458]. Initial Public Offering (IPO) - The company raised total gross proceeds of $230 million from the Public Offering of 23 million Units at $10.00 per Unit, including $30 million from the full exercise of the underwriters' over-allotment option[333][352]. - The Initial Public Offering was completed on October 12, 2021, selling 23,000,000 Units at a price of $10.00 per Unit[428]. - The company incurred transaction costs of $30,639,304 related to the Initial Public Offering[388]. - The gross proceeds from the Initial Public Offering were $230,000,000, with offering costs allocated to Class A ordinary shares totaling $28,518,755[419]. Warrants and Derivative Liabilities - Derivative warrant liabilities were recorded as $373,000 as of December 31, 2022, down from $7,889,000 in the previous year[377]. - The fair value of the Private Placement Warrants decreased from $3,289,000 as of December 31, 2021, to $143,000 as of December 31, 2022, indicating a significant decline of approximately 95.7%[465]. - The Company recognized gains of approximately $7.5 million related to changes in the fair value of warrant liabilities for the year ended December 31, 2022[465]. - The estimated fair value of the Public Warrants was measured based on the listed market price under the ticker IXAQW starting November 2021[461]. Administrative and Operating Expenses - The company incurred operating and formation expenses of approximately $1.4 million for the year ended December 31, 2022[349]. - The company incurred approximately $103,000 in administrative support expenses during the year ended December 31, 2022[354]. - The Company has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans[400].

Financial Performance - For the nine months ended September 30, 2022, the company reported a net income of approximately $7.3 million, primarily due to a gain of approximately $7.0 million from the change in fair value of derivative warrant liabilities[115]. - The company incurred approximately $1.1 million in operating and formation expenses for the nine months ended September 30, 2022[115]. - The company incurred approximately $30,000 in administrative support expenses during the three months ended September 30, 2022[122]. Cash and Proceeds - The company raised total gross proceeds of $230 million from the Initial Public Offering of 23,000,000 Units at $10.00 per Unit[100]. - The underwriters fully exercised their over-allotment option, generating additional gross proceeds of $30 million to the company[120]. - The company had cash held in the Trust Account of approximately $232.6 million as of September 30, 2022, intended for the initial Business Combination[107]. - As of September 30, 2022, the company had approximately $235,000 in cash held outside of the Trust Account and a working capital deficit of approximately $353,000[104]. Business Combination - The company has until April 12, 2023, to consummate a Business Combination, after which a mandatory liquidation may occur if not completed[108]. - The company has not selected any Business Combination target and has not initiated substantive discussions with any potential targets[99]. Concerns and Risks - The company has significant costs expected in pursuit of acquisition plans, raising concerns about its ability to continue as a going concern[109]. - The company qualifies as a smaller reporting company, thus market risk disclosures are not applicable[125]. Accounting and Financial Statements - Recent accounting pronouncements discussed in the unaudited condensed financial statements[124].

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from________to_________ Commission File Number 001-40878 IX ACQUISITION CORP. (Exact name of registrant as specified in its charter) | Cayman Islands ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from________to_________ Commission File Number 001-40878 IX ACQUISITION CORP. (Exact name of registrant as specified in its charter) | Cayman Island ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM________TO_________ COMMISSION FILE NUMBER 001-40878 IX ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 98-1586922 (Stat ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from________to_________ Commission File Number 001-40878 IX ACQUISITION CORP. (Exact name of registrant as specified in its charter) | Cayman Islands ...